BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: McClain KL, Bigenwald C, Collin M, Haroche J, Marsh RA, Merad M, Picarsic J, Ribeiro KB, Allen CE. Histiocytic disorders. Nat Rev Dis Primers 2021;7:73. [PMID: 34620874 DOI: 10.1038/s41572-021-00307-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Serrallach BL, Kralik SF, Tran BH, Huisman TAGM, Patel RP, Allen CE, McClain KL, Gulati N, Dillard-Ilboudo CQ, Hicks MJ, Mohila CA, Desai NK. Neuroimaging in Pediatric Patients with Juvenile Xanthogranuloma of the CNS. AJNR Am J Neuroradiol 2022. [PMID: 36265894 DOI: 10.3174/ajnr.A7683] [Reference Citation Analysis]
2 Hu X, Buhtoiarov IN, Wang C, Sun Z, Zhu Q, Huang W, Yan W, Sun Y. Langerhans Cell Histiocytosis: A Population-based Study of Anatomical Distribution and Treatment Patterns. Journal of Bone Oncology 2022;36:100454. [DOI: 10.1016/j.jbo.2022.100454] [Reference Citation Analysis]
3 Argani P, Matoso A, Pallavajjalla A, Haley L, Tseh-Lin M, Ng J, Chow CW, Lotan T, Mehra R. Xanthomatous Giant Cell Renal Cell Carcinoma: Another Morphologic Form of TSC-associated Renal Cell Carcinoma. Am J Surg Pathol 2022. [PMID: 35941720 DOI: 10.1097/PAS.0000000000001940] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Astigarraga I, García-obregón S, Pérez-martínez A, Gutiérrez-carrasco I, Santa-maría V, Rodríguez-vigil Iturrate C, Lorite Reggiori M, Murciano Carrillo T, Torrent M. Histiocitosis de células de Langerhans. Avances en la patogenia y práctica clínica. Anales de Pediatría 2022;97:130.e1-130.e7. [DOI: 10.1016/j.anpedi.2022.05.002] [Reference Citation Analysis]
5 Astigarraga I, García-Obregón S, Pérez-Martínez A, Gutiérrez-Carrasco I, Santa-María V, Iturrate CR, Reggiori ML, Carrillo TM, Torrent M; Grupo de Histiocitosis de la Sociedad Española de Hematología y Oncología Pediátricas (SEHOP). Langerhans cell histiocytosis. Advances in pathogenesis and clinical practice. An Pediatr (Engl Ed) 2022:S2341-2879(22)00148-X. [PMID: 35869015 DOI: 10.1016/j.anpede.2022.05.005] [Reference Citation Analysis]
6 Serrallach BL, Orman G, Boltshauser E, Hackenberg A, Desai NK, Kralik SF, Huisman TAGM. Neuroimaging in cerebellar ataxia in childhood: A review. J Neuroimaging 2022. [PMID: 35749078 DOI: 10.1111/jon.13017] [Reference Citation Analysis]
7 Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, Bejar R, Berti E, Busque L, Chan JKC, Chen W, Chen X, Chng WJ, Choi JK, Colmenero I, Coupland SE, Cross NCP, De Jong D, Elghetany MT, Takahashi E, Emile JF, Ferry J, Fogelstrand L, Fontenay M, Germing U, Gujral S, Haferlach T, Harrison C, Hodge JC, Hu S, Jansen JH, Kanagal-Shamanna R, Kantarjian HM, Kratz CP, Li XQ, Lim MS, Loeb K, Loghavi S, Marcogliese A, Meshinchi S, Michaels P, Naresh KN, Natkunam Y, Nejati R, Ott G, Padron E, Patel KP, Patkar N, Picarsic J, Platzbecker U, Roberts I, Schuh A, Sewell W, Siebert R, Tembhare P, Tyner J, Verstovsek S, Wang W, Wood B, Xiao W, Yeung C, Hochhaus A. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms. Leukemia 2022. [PMID: 35732831 DOI: 10.1038/s41375-022-01613-1] [Cited by in Crossref: 44] [Cited by in F6Publishing: 77] [Article Influence: 44.0] [Reference Citation Analysis]
8 Salari B, Dehner LP. Juvenile and adult xanthogranuloma: A 30-year single-center experience and review of the disorder and its relationship to other histiocytoses. Annals of Diagnostic Pathology 2022;58:151940. [DOI: 10.1016/j.anndiagpath.2022.151940] [Reference Citation Analysis]
9 Abeykoon JP, Lasho TL, Dasari S, Rech KL, Ranatunga WK, Manske MK, Tischer A, Ravindran A, Young JR, Tobin WO, Flanagan EP, Nowakowski KE, Ruan GJ, Shah MV, Bennani NN, Vassallo R, Ryu JH, Koster MJ, Davidge-Pitts CJ, Patnaik MM, Wu X, Witzig TE, Goyal G, Go RS; Mayo Clinic-University of Alabama at Birmingham Histiocytosis Working Group. Sustained, complete response to pexidartinib in a patient with CSF1R-mutated Erdheim-Chester disease. Am J Hematol 2022;97:293-302. [PMID: 34978715 DOI: 10.1002/ajh.26441] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Lasocki A, Seymour J. Central nervous system manifestations of systemic haematological malignancies and key differentials. Clinical Radiology 2022. [DOI: 10.1016/j.crad.2022.01.043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Abeykoon JP, Ravindran A, Rech KL, Young JR, Oliver Tobin W, Shah MV, Nora Bennani N, Vassallo R, Ryu JH, Koster MJ, Davidge-Pitts CJ, Goyal G, Go RS; Mayo Clinic-University of Alabama at Birmingham Histiocytosis Working Group. Mimics of Erdheim-Chester disease. Br J Haematol 2021. [PMID: 34799853 DOI: 10.1111/bjh.17949] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]